• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

喉鳞状细胞癌危险因素评估:一项单中心回顾性研究

Evaluation of Risk Factors for Laryngeal Squamous Cell Carcinoma: A Single-Center Retrospective Study.

作者信息

Zhang Qihe, Wang Huanhuan, Zhao Qin, Zhang Yuyu, Zheng Zhuangzhuang, Liu Shiyu, Liu Zijing, Meng Lingbin, Xin Ying, Jiang Xin

机构信息

Department of Radiation Oncology, The First Hospital of Jilin University, Changchun, China.

Jilin Provincial Key Laboratory of Radiation Oncology & Therapy, The First Hospital of Jilin University, Changchun, China.

出版信息

Front Oncol. 2021 Feb 25;11:606010. doi: 10.3389/fonc.2021.606010. eCollection 2021.

DOI:10.3389/fonc.2021.606010
PMID:33718158
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7947300/
Abstract

BACKGROUND

The survival rate of patients with laryngeal squamous cell carcinoma (LSCC) is correlated with several factors. However, the independent prognostic factors of patients with LSCC remain unclear. Thus, we sought to identify prognostic factors affecting LSCC outcomes in the Chinese population.

METHODS

The survival and potential prognostic factors of 211 patients with LSCC between April 2011 and July 2019 were retrospectively analyzed. Overall survival (OS) and progression free survival (PFS) were estimated by the Kaplan Meier method, and a log-rank test was used to compare the possible prognostic factors between different groups. The Cox proportional hazard model was used to perform multivariable analysis of significant covariants.

RESULTS

A total of 211 LSCC patients were included, of which 164 (77.7%) were male and 47 (22.3%) were female. Mean age was 62.19 ± 8.328 years. A univariate analysis showed that seven factors including pathological differentiation, clinical stage, tobacco consumption, alcohol consumption, T stage, N stage, and concurrent chemoradiotherapy were correlated with survival (<0.05). Cox proportional hazards regression analyses revealed that clinic stage (hazard ratio=3.100, p=0.048), pathological differentiation (hazard ratio = 2.538, p=0.015), alcohol consumption (hazard ratio = 8.456, p =0.004) were associated with OS in LSCC. Pathological differentiation (hazard ratio =5.677, p=0.000), alcohol consumption (hazard ratio =6.766, p=0.000) were associated with PFS in LSCC.

CONCLUSIONS

Pathological differentiation, alcohol consumption, are independent prognostic factors and predictors of recurrence in LSCC. These factors could help inform guidelines for clinical treatment and prognosis.

摘要

背景

喉鳞状细胞癌(LSCC)患者的生存率与多种因素相关。然而,LSCC患者的独立预后因素仍不清楚。因此,我们试图在中国人群中确定影响LSCC预后的因素。

方法

回顾性分析2011年4月至2019年7月期间211例LSCC患者的生存情况及潜在预后因素。采用Kaplan-Meier法估计总生存期(OS)和无进展生存期(PFS),并使用对数秩检验比较不同组之间可能的预后因素。采用Cox比例风险模型对显著协变量进行多变量分析。

结果

共纳入211例LSCC患者,其中男性164例(77.7%),女性47例(22.3%)。平均年龄为62.19±8.328岁。单因素分析显示,病理分化、临床分期、吸烟、饮酒、T分期、N分期和同步放化疗7个因素与生存率相关(<0.05)。Cox比例风险回归分析显示,临床分期(风险比=3.100,p=0.048)、病理分化(风险比=2.538,p=0.015)、饮酒(风险比=8.456,p=0.004)与LSCC的OS相关。病理分化(风险比=5.677,p=0.000)、饮酒(风险比=6.766,p=0.000)与LSCC的PFS相关。

结论

病理分化、饮酒是LSCC的独立预后因素和复发预测因素。这些因素有助于为临床治疗和预后指南提供参考。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95c5/7947300/12dcb27a1a6a/fonc-11-606010-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95c5/7947300/6348209afb46/fonc-11-606010-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95c5/7947300/12dcb27a1a6a/fonc-11-606010-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95c5/7947300/6348209afb46/fonc-11-606010-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95c5/7947300/12dcb27a1a6a/fonc-11-606010-g002.jpg

相似文献

1
Evaluation of Risk Factors for Laryngeal Squamous Cell Carcinoma: A Single-Center Retrospective Study.喉鳞状细胞癌危险因素评估:一项单中心回顾性研究
Front Oncol. 2021 Feb 25;11:606010. doi: 10.3389/fonc.2021.606010. eCollection 2021.
2
Retrospective analysis of 659 laryngeal squamous cell carcinoma patients treated with open laryngeal function-preserving operations.对659例接受开放性喉功能保留手术治疗的喉鳞状细胞癌患者进行回顾性分析。
Acta Otolaryngol. 2018 Nov;138(11):1043-1050. doi: 10.1080/00016489.2018.1500711.
3
Downregulation of miR-29c-3p is associated with a poor prognosis in patients with laryngeal squamous cell carcinoma.miR-29c-3p 的下调与喉鳞状细胞癌患者的不良预后相关。
Diagn Pathol. 2019 Oct 15;14(1):109. doi: 10.1186/s13000-019-0893-2.
4
Impact of stage, management and recurrence on survival rates in laryngeal cancer.分期、治疗及复发对喉癌生存率的影响
PLoS One. 2017 Jul 14;12(7):e0179371. doi: 10.1371/journal.pone.0179371. eCollection 2017.
5
MicroRNA-9 as a novel prognostic biomarker in human laryngeal squamous cell carcinoma.微小RNA-9作为人喉鳞状细胞癌的一种新型预后生物标志物。
Int J Clin Exp Med. 2014 Dec 15;7(12):5523-8. eCollection 2014.
6
Association between pathological differentiation and survival outcomes of patients with laryngeal squamous cell carcinoma.喉鳞状细胞癌患者的病理分化与生存结局的关系。
Eur Arch Otorhinolaryngol. 2022 Sep;279(9):4595-4604. doi: 10.1007/s00405-022-07420-9. Epub 2022 May 18.
7
Association Between Alcohol Dehydrogenase Polymorphisms and the Recurrence of Laryngeal Carcinoma.醇脱氢酶多态性与喉癌复发的相关性。
Laryngoscope. 2022 Nov;132(11):2169-2176. doi: 10.1002/lary.30083. Epub 2022 Feb 25.
8
Low expression of PTK6/Brk predicts poor prognosis in patients with laryngeal squamous cell carcinoma.PTK6/Brk 低表达预示着喉鳞癌患者预后不良。
J Transl Med. 2013 Mar 7;11:59. doi: 10.1186/1479-5876-11-59.
9
[Survivin expression in laryngeal squamous cell carcinoma and its relationship with clinical factors].[生存素在喉鳞状细胞癌中的表达及其与临床因素的关系]
Ai Zheng. 2004 Nov;23(11 Suppl):1493-7.
10
A novel prognostic score model incorporating CDGSH iron sulfur domain2 (CISD2) predicts risk of disease progression in laryngeal squamous cell carcinoma.一种纳入CDGSH铁硫结构域2(CISD2)的新型预后评分模型可预测喉鳞状细胞癌的疾病进展风险。
Oncotarget. 2016 Apr 19;7(16):22720-32. doi: 10.18632/oncotarget.8150.

引用本文的文献

1
Compatibility of endoscopic examination using i-scan technology with histopathology results in laryngeal carcinoma: prospective observational study.i-scan技术在内镜检查中与喉癌组织病理学结果的兼容性:前瞻性观察研究
PeerJ. 2025 Aug 7;13:e19552. doi: 10.7717/peerj.19552. eCollection 2025.
2
The Association Between Clinical Outcome and Expression of DNMT1, 3A, and 3B in Locally Advanced Laryngeal Carcinomas Treated by Definitive Radiotherapy.根治性放疗治疗的局部晚期喉癌中DNMT1、3A和3B的表达与临床结局的关系
Cancers (Basel). 2025 May 22;17(11):1741. doi: 10.3390/cancers17111741.
3
Global, regional, and national burden of laryngeal cancer attributable to smoking, 1990-2021, and projections to 2036: a systematic analysis of the Global Burden of Disease study 2021.

本文引用的文献

1
Survival prediction and treatment strategies for patients with advanced laryngeal carcinoma: a population-based study.基于人群的研究:晚期喉癌患者的生存预测和治疗策略。
Int J Clin Oncol. 2020 Aug;25(8):1483-1491. doi: 10.1007/s10147-020-01688-9. Epub 2020 May 27.
2
Prognostic factors in laryngeal squamous cell carcinoma.喉鳞状细胞癌的预后因素
Laryngoscope Investig Otolaryngol. 2020 Jan 27;5(1):74-81. doi: 10.1002/lio2.353. eCollection 2020 Feb.
3
Cancer statistics, 2020.癌症统计数据,2020 年。
1990年至2021年全球、区域和国家归因于吸烟的喉癌负担及到2036年的预测:全球疾病负担研究2021的系统分析
Front Public Health. 2025 May 9;13:1583045. doi: 10.3389/fpubh.2025.1583045. eCollection 2025.
4
N6-methyladenosine RNA modification in head and neck squamous cell carcinoma (HNSCC): current status and future insights.N6-甲基腺苷 RNA 修饰在头颈部鳞状细胞癌(HNSCC)中的研究现状和未来展望。
Med Oncol. 2024 Nov 24;42(1):12. doi: 10.1007/s12032-024-02566-4.
5
Differential molecular characterization of human papillomavirus-associated oropharyngeal squamous cell carcinoma and its prognostic value.人乳头瘤病毒相关口咽鳞状细胞癌的差异分子特征及其预后价值。
J Cell Mol Med. 2024 Oct;28(19):e70073. doi: 10.1111/jcmm.70073.
6
DIAPH2 gene polymorphisms and laryngeal cancer risk in men.DIAPH2 基因多态性与男性喉癌风险。
J Cancer Res Clin Oncol. 2024 Jun 7;150(6):295. doi: 10.1007/s00432-024-05820-4.
7
Citalopram, an antipsychotic agent, induces G1/G0 phase cell cycle arrest and promotes apoptosis in human laryngeal carcinoma HEP-2 cells.西酞普兰是一种抗精神病药物,可诱导人喉癌细胞 HEP-2 细胞发生 G1/G0 期细胞周期阻滞并促进细胞凋亡。
Med Oncol. 2024 Apr 4;41(5):105. doi: 10.1007/s12032-024-02338-0.
8
Role of Human Papilloma Virus 16/18 In Laryngeal Carcinoma with Correlation to the Expression of Cyclin D1, p53, p16 and EGFR.人乳头瘤病毒16/18在喉癌中的作用及其与细胞周期蛋白D1、p53、p16和表皮生长因子受体表达的相关性
Pak J Med Sci. 2023 Nov-Dec;39(6):1768-1773. doi: 10.12669/pjms.39.6.8220.
9
MMP-9 and CCR7 as Possible Predictors of Lymph Node Metastasis in Laryngeal Squamous Cell Carcinoma.基质金属蛋白酶-9和趋化因子受体7作为喉鳞状细胞癌淋巴结转移的可能预测指标
Iran J Pathol. 2023 Spring;18(2):156-164. doi: 10.30699/ijp.2023.563014.2986. Epub 2023 Jun 20.
10
The role of non-classical and chain-related human leukocyte antigen polymorphisms in laryngeal squamous cell carcinoma.非经典和连锁相关人类白细胞抗原多态性在喉鳞状细胞癌中的作用。
Mol Biol Rep. 2023 Sep;50(9):7245-7252. doi: 10.1007/s11033-023-08629-5. Epub 2023 Jul 7.
CA Cancer J Clin. 2020 Jan;70(1):7-30. doi: 10.3322/caac.21590. Epub 2020 Jan 8.
4
Association of clinical factors with survival outcomes in laryngeal squamous cell carcinoma (LSCC).临床因素与喉鳞状细胞癌(LSCC)生存结局的相关性。
PLoS One. 2019 Nov 20;14(11):e0224665. doi: 10.1371/journal.pone.0224665. eCollection 2019.
5
Locally advanced hypopharyngeal and laryngeal cancer: Influence of HPV status.局部晚期下咽和喉癌:HPV 状态的影响。
Radiother Oncol. 2019 Nov;140:6-9. doi: 10.1016/j.radonc.2019.05.013. Epub 2019 Jun 4.
6
The prognostic value of sex hormone receptors expression in laryngeal carcinoma.性激素受体表达在喉癌中的预后价值。
Tissue Cell. 2019 Apr;57:84-89. doi: 10.1016/j.tice.2019.02.007. Epub 2019 Feb 22.
7
Tumour stage and gender predict recurrence and second primary malignancies in head and neck cancer: a multicentre study within the INHANCE consortium.肿瘤分期和性别可预测头颈部癌症的复发和第二原发恶性肿瘤:INHANCE 联盟内的一项多中心研究。
Eur J Epidemiol. 2018 Dec;33(12):1205-1218. doi: 10.1007/s10654-018-0409-5. Epub 2018 May 19.
8
WRAP53β, survivin and p16INK4a expression as potential predictors of radiotherapy/chemoradiotherapy response in T2N0-T3N0 glottic laryngeal cancer.WRAP53β、survivin和p16INK4a表达作为T2N0 - T3N0声门型喉癌放疗/放化疗反应的潜在预测指标
Oncol Rep. 2017 Oct;38(4):2062-2068. doi: 10.3892/or.2017.5898. Epub 2017 Aug 11.
9
Risk of Recurrence in Laryngeal Cancer.喉癌复发风险
PLoS One. 2016 Oct 7;11(10):e0164068. doi: 10.1371/journal.pone.0164068. eCollection 2016.
10
Pattern of failure in 5001 patients treated for glottic squamous cell carcinoma with curative intent - A population based study from the DAHANCA group.5001例接受根治性治疗的声门鳞状细胞癌患者的失败模式——丹麦头颈癌组的一项基于人群的研究
Radiother Oncol. 2016 Feb;118(2):257-66. doi: 10.1016/j.radonc.2016.02.006. Epub 2016 Feb 17.